Wednesday, 14 April 2021
This website uses cookies. By using our site you agree to our privacy policy
Username:
Password:
Lost username/password
Create an account
  • Home
  • About Us
    • Contributing Faculty
    • Supporters
    • Site Map
    • Accreditation
    • Press Room
    • Contact Us
  • Reference
    • Clinical Trial Highlights
    • Clinical Case Snapshots
    • Clinical Pearls Podcasts
    • Clinical Expert Commentaries
    • FAQ Library
    • Case Discussion
    • Downloadable Slides
    • Expert Interview Series
    • HL e-Newsletter Series
    • Articles
    • COVID-19 Resource Center
  • Conferences
  • Continuing Education
    • Accredited E-Newsletter Series
    • Annual Meeting Highlights
    • Practice Essentials
    • CD30 e-Monograph
    • Clinical Discussion Series
    • Commentaries in HL
    • Contemporary Therapy e-Monograph
  • CE for Nurses

Clinical Pearls Podcasts

MediCom Oncology Clinical Pearls Podcasts provide practical, evidence-based recommendations on real-world issues in the clinical setting. For more tips and advice on best practices in patients, subscribe to our channel on iTunes.


What are the pros and cons of radiation therapy?
Matthew Matasar, MD
Clinical Pearls Podcasts published on December 7, 2017
Read More
What defines high-quality survivorship care for patients treated for classical Hodgkin lymphoma?
Matthew Matasar, MD
Clinical Pearls Podcasts published on November 6, 2017
Read More
What may be the future role for brentuximab vedotin in newly diagnosed Hodgkin lymphoma?
Matthew Matasar, MD
Clinical Pearls Podcasts published on October 23, 2017
Read More
How does the safety profile of the new and emerging anti-PD 1 antibodies differ from chemotherapy?
Alison J. Moskowitz, MD
Clinical Pearls Podcasts published on July 11, 2017
Read More
Is the AE profile of BV the same or different from traditional monoclonal antibody therapies?
Alison J. Moskowitz, MD
Clinical Pearls Podcasts published on May 10, 2017
Read More
What are some of the more common adverse reactions associated with brentuximab vedotin and how are they most often managed?
Alison J. Moskowitz, MD
Clinical Pearls Podcasts published on April 7, 2017
Read More
The new FDA approval of pembrolizumab for cHL
Anas Younes, MD
Clinical Pearls Podcasts published on March 22, 2017
Read More

Results 1 - 7 of 7

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMyeloma.com | ManagingMDS.com | ManagingMPN.com | PartnersinPancreaticCancer.com | PracticalOncologist.com | EmergingSolutionsinPain.com | MediComWorldwide.com

©2021 MediCom Worldwide, Inc. All rights reserved

  • Privacy, Terms, and Conditions
  • Contact Us